Logo image of AMPLI.PA

AMPLITUDE SURGICAL SAS (AMPLI.PA) Stock Price, Quote, News and Overview

EPA:AMPLI - Euronext Paris - Matif - FR0012789667 - Common Stock - Currency: EUR

3.4  +0.04 (+1.19%)

AMPLI.PA Quote, Performance and Key Statistics

AMPLITUDE SURGICAL SAS

EPA:AMPLI (3/7/2025, 7:00:00 PM)

3.4

+0.04 (+1.19%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High3.66
52 Week Low2.7
Market Cap163.27M
Shares48.02M
Float11.59M
Yearly DividendN/A
Dividend YieldN/A
PE113.33
Fwd PEN/A
Earnings (Next)04-17 2025-04-17
IPO06-26 2015-06-26


AMPLI.PA short term performance overview.The bars show the price performance of AMPLI.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5

AMPLI.PA long term performance overview.The bars show the price performance of AMPLI.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30

The current stock price of AMPLI.PA is 3.4 EUR. In the past month the price decreased by -1.16%. In the past year, price increased by 2.41%.

AMPLITUDE SURGICAL SAS / AMPLI Daily stock chart

AMPLI.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 29.15 217.38B
IUI1.DE INTUITIVE SURGICAL INC 69.31 166.86B
BSX.DE BOSTON SCIENTIFIC CORP 39.18 133.56B
1BSX.MI BOSTON SCIENTIFIC CORP 39.52 133.38B
1MDT.MI MEDTRONIC PLC 17.48 113.17B
2M6.DE MEDTRONIC PLC 17.56 110.81B
1SHL.MI SIEMENS HEALTHINEERS AG 25.27 60.49B
BOX.DE BECTON DICKINSON AND CO 16.4 60.33B
SHL.DE SIEMENS HEALTHINEERS AG 23.49 59.08B
1EW.MI EDWARDS LIFESCIENCES CORP 26.07 39.21B
EWL.DE EDWARDS LIFESCIENCES CORP 26.65 37.76B
DC4.DE DEXCOM INC 48.5 28.81B

About AMPLI.PA

Company Profile

AMPLI logo image Amplitude Surgical SAS engages in the manufacturing, marketing and design of orthopedic products. The company is headquartered in Valence, Auvergne-Rhone-Alpes and currently employs 428 full-time employees. The company went IPO on 2015-06-26. The firm offers the AMPLIVISION system, a computer navigation workstation and its related software, which is fully developed by the Company in collaboration with surgeons. Each implant is validated mechanically by creating models and running tests on simulators. Amplitude Surgical SAS relies on the expertise of its design offices and on scientific partnerships to internally design and develop its implants and automatic or computer-navigated instruments. The company operates through ofab Orthopedie, a strategic industrial subcontractor

Company Info

AMPLITUDE SURGICAL SAS

11 Cours Jacques Offenbach

VALENCE AUVERGNE-RHONE-ALPES FR

Employees: 416

Company Website: https://www.amplitude-surgical.com/

Investor Relations: https://www.amplitude-surgical.com/en/documentation/reference-documents-financial-reports

Phone: 33475418741

AMPLITUDE SURGICAL SAS / AMPLI.PA FAQ

What is the stock price of AMPLITUDE SURGICAL SAS today?

The current stock price of AMPLI.PA is 3.4 EUR. The price increased by 1.19% in the last trading session.


What is the ticker symbol for AMPLITUDE SURGICAL SAS stock?

The exchange symbol of AMPLITUDE SURGICAL SAS is AMPLI and it is listed on the Euronext Paris - Matif exchange.


On which exchange is AMPLI.PA stock listed?

AMPLI.PA stock is listed on the Euronext Paris - Matif exchange.


What is AMPLITUDE SURGICAL SAS worth?

AMPLITUDE SURGICAL SAS (AMPLI.PA) has a market capitalization of 163.27M EUR. This makes AMPLI.PA a Micro Cap stock.


How many employees does AMPLITUDE SURGICAL SAS have?

AMPLITUDE SURGICAL SAS (AMPLI.PA) currently has 416 employees.


What are the support and resistance levels for AMPLITUDE SURGICAL SAS (AMPLI.PA) stock?

AMPLITUDE SURGICAL SAS (AMPLI.PA) has a support level at 3.24 and a resistance level at 3.61. Check the full technical report for a detailed analysis of AMPLI.PA support and resistance levels.


Should I buy AMPLITUDE SURGICAL SAS (AMPLI.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does AMPLITUDE SURGICAL SAS (AMPLI.PA) stock pay dividends?

AMPLI.PA does not pay a dividend.


When does AMPLITUDE SURGICAL SAS (AMPLI.PA) report earnings?

AMPLITUDE SURGICAL SAS (AMPLI.PA) will report earnings on 2025-04-17.


What is the Price/Earnings (PE) ratio of AMPLITUDE SURGICAL SAS (AMPLI.PA)?

The PE ratio for AMPLITUDE SURGICAL SAS (AMPLI.PA) is 113.33. This is based on the reported non-GAAP earnings per share of 0.03 and the current share price of 3.4 EUR. Check the full fundamental report for a full analysis of the valuation metrics for AMPLI.PA.


AMPLI.PA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to AMPLI.PA. When comparing the yearly performance of all stocks, AMPLI.PA turns out to be only a medium performer in the overall market: it outperformed 55.84% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AMPLI.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AMPLI.PA. AMPLI.PA has a medium profitability rating, but doesn't score so well on its financial health evaluation.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AMPLI.PA Financial Highlights

Over the last trailing twelve months AMPLI.PA reported a non-GAAP Earnings per Share(EPS) of 0.03. The EPS decreased by -96.07% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.44%
ROA 0.55%
ROE 1.59%
Debt/Equity 1.08
Chartmill High Growth Momentum
EPS Q2Q%-96.06%
Sales Q2Q%3.59%
EPS 1Y (TTM)-96.07%
Revenue 1Y (TTM)5.81%

AMPLI.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 40% to AMPLI.PA. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners0.11%
Ins Owners0.26%
Short Float %N/A
Short RatioN/A
Analysts
Analysts40
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A